ADJUNCTIVE VARENICLINE TREATMENT WITH ANTIPSYCHOTIC MEDICATIONS IN PATIENT WITH SCHIZOPHRENIA: A PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
Shim, Joo-Cheol [1 ]
Jung, Do-Un [2 ]
Jung, Sung-Soo [3 ]
Seo, Young-Soo [3 ]
Kong, Bo-Geum [1 ]
Oh, Min-Kyung [1 ]
McMahon, Robert P. [4 ]
Kelly, Deanna L. [4 ]
机构：
[1] Inje Univ, Pusan, South Korea
[2] Dongrae Hosp, Pusan, South Korea
[3] Nanumhaengbok Hosp, Pusan, South Korea
[4] Univ Maryland, Baltimore, MD 21201 USA
来源：
SCHIZOPHRENIA RESEARCH | 2010年 / 117卷 / 2-3期
关键词：
D O I：
10.1016/j.schres.2010.02.952
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：500 / 500
页数：1
相关论文
共 50 条
  • [31] A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia
    Akhondzadeh, Shahin
    Gerami, Maryam
    Noroozian, Maryam
    Karamghadiri, Narges
    Ghoreishi, Aboulfazl
    Abbasi, Seyed-Hesameddin
    Rezazadeh, Sams-Ali
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (08): : 1810 - 1815
  • [32] The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
    Li, Meijuan
    Liu, Ying
    Qiu, Yuying
    Zhang, Jing
    Zhang, Yonghui
    Zhao, Yongping
    Jia, Qiong
    Li, Jie
    [J]. PSYCHIATRY RESEARCH, 2021, 300
  • [33] A Pilot Randomized, Placebo-Controlled Trial of Glycine for Treatment of Schizophrenia and Alcohol Dependence
    Serrita, Jane
    Ralevski, Elizabeth
    Yoon, Gihyun
    Petrakis, Ismene
    [J]. JOURNAL OF DUAL DIAGNOSIS, 2019, 15 (01) : 46 - 55
  • [34] A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia
    Friedman, JI
    Adler, DN
    Howanitz, E
    Harvey, PD
    Brenner, G
    Temporini, H
    White, L
    Parrella, M
    Davis, KL
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 51 (05) : 349 - 357
  • [35] A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia
    Friedman, JI
    Adler, DN
    Howanitz, E
    Harvey, PD
    Brenner, G
    Temporini, H
    White, L
    Parrella, M
    Davis, KL
    [J]. SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 9 - 9
  • [36] Lamotrigine in treatment-resistant schizophrenia:: A randomized placebo-controlled crossover trial
    Tiihonen, J
    Hallikainen, T
    Ryynänen, OP
    Repo-Tiihonen, E
    Kotilainen, I
    Eronen, M
    Toivonen, P
    Wahlbeck, K
    Putkonen, A
    [J]. BIOLOGICAL PSYCHIATRY, 2003, 54 (11) : 1241 - 1248
  • [37] Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial
    Nakamura, Mitsutaka
    Ogasa, Masaaki
    Guarino, John
    Phillips, Debra
    Severs, Joseph
    Cucchiaro, Josephine
    Loebel, Antony
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (06) : 829 - 836
  • [38] A PLACEBO-CONTROLLED TRIAL OF TRIHEXYPHENIDYL IN UNMEDICATED PATIENTS WITH SCHIZOPHRENIA
    GOFF, DC
    AMICO, E
    DREYFUSS, D
    CIRAULO, D
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1994, 151 (03): : 429 - 431
  • [39] Placebo-controlled trial of glycine added to clozapine in schizophrenia
    Evins, AE
    Fitzgerald, SM
    Wine, L
    Rosselli, R
    Goff, DC
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (05): : 826 - 828
  • [40] What Justifies a Placebo-Controlled Trial of Varenicline for Smoking Cessation in Patients With COPD?
    Kotz, Daniel
    van Schayck, Onno C. P.
    [J]. CHEST, 2011, 139 (04) : 968 - 969
12345